Form SCHEDULE 13D - General statement of acquisition of beneficial ownership
22 Mayo 2024 - 3:50PM
Edgar (US Regulatory)
Exhibit 99.1
JOINT FILING AGREEMENT
In accordance
with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf
of each of them of a statement on Schedule 13D and all amendments thereto with respect to the common stock of ImmuCell Corporation, and that this Joint Filing Agreement (this “Agreement”) be included as an Exhibit to such joint filing.
This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
In witness hereof,
the undersigned hereby executed this Agreement this 22nd day of May, 2024.
SRK CAPITAL, LLC
By: /s/ Sean Kirkwood
Name: Sean Kirkwood
Title: Manager
SRK FUND I,
LP
By: SRK Capital, LLC,
as general partner
By: /s/ Sean Kirkwood
Name: Sean Kirkwood
Title: Manager
/s/ Sean Kirkwood
Sean Kirkwood, individually
ImmuCell (NASDAQ:ICCC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
ImmuCell (NASDAQ:ICCC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024